Results 231 to 240 of about 308,174 (298)

HIV drug resistance, early treatment outcomes and impact of guidelines compliance after protease inhibitor-based second-line failure in a dedicated resistance clinic in western Kenya: a retrospective cohort study. [PDF]

J Int AIDS Soc
Humphrey JM, Ali SM, DeLong A, Novitsky V, Sang E, Jawed B, Kemboi E, Ngetich C, Goodrich S, Gardner A, Hogan JW, Kantor R.   +11 more
europepmc   +1 more source

Systematic screening for age‐related comorbidities: Health care optimization among persons with HIV in an outpatient setting

HIV Medicine, EarlyView.
Abstract Background Age‐related comorbidities occur earlier and more frequently in people with HIV (PWH) than in the general population and have emerged as a key challenge in long‐term HIV care. Unfortunately, many of these conditions remain undiagnosed, and systematic screening in clinical practice remains limited.
Anna Katrine Haslund Roed, Anne‐Mette Lebech, Sabine Singh, Ole Kirk, Susanne Dam Nielsen   +4 more
wiley   +1 more source

A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa. [PDF]

J Int AIDS Soc
Parikh UM, Kudrick LD, Levy L, Bosek E, Chohan BH, Mukui I, Masyuko S, Ndlovu N, Mahaka I, Mugurungi O, Ncube G, Hettema A, Matse SN, Mullick S, Wallis CL, Heaps AL, Penrose KJ, McCormick KD, Wiesner L, Anderson PL, Peterson JM, Celum C, Richardson BA, Castor D, Allen S, Torjesen K, Mellors JW, Global Evaluation of Microbicide Sensitivity (GEMS) Project.   +27 more
europepmc   +1 more source

Mortality trends for diabetes mellitus, hypertension and cardiovascular disease among people living with and without HIV in Brazil during the COVID‐19 pandemic, 2020–2022

HIV Medicine, EarlyView.
Abstract Introduction People living with HIV (PLWH) face an increasing burden of non‐AIDS‐related chronic conditions. However, how the COVID‐19 pandemic affected chronic disease‐related mortality in this population remains unclear. We assessed changes in mortality among PLWH in Brazil during the COVID‐19 pandemic.
Tatyellen Natasha da Costa Oliveira, Rodrigo C. Moreira, Luiz Max Carvalho, Flávio Codeço Coelho, Marcelo Ferreira da Costa Gomes, Leonardo S. Bastos, Laís Picinini Freitas, Antonio G. Pacheco   +7 more
wiley   +1 more source

Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. [PDF]

J Acquir Immune Defic Syndr
Bishop MD, Korutaro V, Boyce CL, Beck IA, Styrchak SM, Knowles K, Ziemba L, Brummel SS, Coletti A, Jean-Philippe P, Chakhtoura N, Vhembo T, Cassim H, Owor M, Fairlie L, Moyo S, Chinula L, Lockman S, Frenkel LM.   +18 more
europepmc   +1 more source

Real‐world clinical and laboratory changes after switching to two‐drug regimen in HIV‐suppressed individuals: 48 weeks and beyond

HIV Medicine, EarlyView.
Abstract Introduction Two‐drug regimens (2DRs) may reduce long‐term drug toxicities and drug‐drug interactions for people with HIV (PWH) on antiretroviral therapy (ART). This study evaluated clinical and laboratory outcomes in PWH who switched from standard ART to dolutegravir and lamivudine (DTG + 3TC) in real‐world settings.
Tommy Hing‐cheung Tang, Ruby Tsz‐shan Kwong, Phillip Chan, Kwok‐wai Lam, Helen Shuk‐ying Chan, Man‐yee Chu, Wilson Lam, Tak‐chiu Wu, Wai‐shing Leung, Sai‐kwong Yung, Wan‐man Ting, Annabel Kai‐tung Choy, Joe Lok‐fung Tung, Jason Ka‐wah Fong, Daniel Kai‐yeung Yeung, Man‐po Lee   +15 more
wiley   +1 more source

HIV drug resistance to integrase inhibitors in low- and middle-income countries. [PDF]

Nat Med
Fokam J, Inzaule S, Colizzi V, Perno CF, Kaseya J, Ndembi N.   +5 more
europepmc   +1 more source

An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe

HIV Medicine, EarlyView.
Abstract Background Complicated consent procedures for bloodborne virus (HIV, HBV and HCV) testing present barriers to implementation, particularly in non‐specialist healthcare settings. European and global guidelines no longer recommend written consent. An overview of testing consent requirements in Europe is lacking. Methods An online survey on legal
Annemarie Rinder Stengaard, Ann K. Sullivan, Daniel Simões, Josephine Diderichsen, Dorthe Raben, Jürgen K. Rockstroh, on behalf of the EuroTEST Steering Committee, Ann K Sullivan, Ben Collins, Brian Gazzard, Carlos Mejia, Cary James, Casper Rokx, Daniela Rojas Castro, Deniz Gökengin, Ferenc Bagyinszky, Francesco Negro, Igor Karpov, Irith De Baetselier, Jack Lambert, Jens D. Lundgren, Johanna Brännström, Jordi Casabona, Jürgen Rockstroh, Olesia Murha, Lella Cosmaro, Liudmyla Maistat, Loreta Kondili, Magnus Unemo, Maria Prins, Michael Rayment, Milosz Parczewski, Mojca Matičič, Nicoletta Policek, Nikos Dedes, Nino Tsereteli, Olga Grozdetska, Sara Croxford, Tom Platteau, Valerie Delpech, Yazdan Yazdanpanah, Anastasia Pharris, Stela Bivol, Thomas Seyler   +43 more
wiley   +1 more source

Portable Nanopore sequencing solution for next-generation HIV drug resistance testing. [PDF]

J Clin Virol
Park SY, Faraci G, Ganesh K, Dubé MP, Lee HY.   +4 more
europepmc   +1 more source

Empowerment for People With Lived Experience of the Justice System? Peer Leadership and the ‘Spectrum of Public Participation’

The Howard Journal of Crime and Justice, EarlyView.
ABSTRACT Drawing from Arnstein's original ladder model, and the political philosophy of Dewey, Fraser and Pitkin, it is argued that people with lived experience of the justice system require a coherent social movement if they are to be collectively empowered by lived experience consultations.
Aaron Hart
wiley   +1 more source